8-K ·Filed Jul 20, 2026

PSNL

Personalis, Inc.
BULLISH
Impact 7/10
Horizonmonths Processed2mo ago SEC0001193125-26-308488
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

PSNL shares should trade near the $16.25 deal price with a small spread reflecting closing risk and time value. Monitor the S-4 proxy filing for shareholder vote details and any regulatory developments. The deal structure (stock with cash option) introduces TEM stock price risk — if TEM falls below $46, PSNL can terminate. Spread-watching is warranted.

DirectionBullish
Confidencehigh
Horizonmonths
Latest settled — T+20d ⚠ clustered
PSNL ▲ +4.12% at T+20d
LONG call ✓ call won +4.12% · α vs SPY +0.00% · entry $13.34 → $13.89
Next anchor: T+60d in 11d
Latest observation: T+49 -33.93% FF3 residual α
Entry anchored
Jul 17, 03:59 PM ET
via exchange tick
T+1d
+0.75%
call +0.75% · α -0.08%
$13.44
settled 2mo ago
T+5d
-11.69%
call -11.69% · α -11.27%
$11.78
settled 2mo ago
T+20d
+4.12%
call +4.12% · α +0.00%
$13.89
settled 7w ago
T+60d
—
call — · α —
—
in 11d

Price Chart

Loading chart...

Executive Summary

Personalis (PSNL) announced a definitive agreement to be acquired by Tempus AI (TEM) for $16.25 per share in a stock transaction valued at $1.5B enterprise value net of Tempus' existing stake. The deal represents a 6% premium to Friday's close and a 28% premium to the 30-day VWAP, with closing expected in late 2026 or early 2027. Preliminary Q2 2026 revenue of $22.4M and 10,384 clinical tests (33% sequential growth) underscore the commercial momentum that drove the acquisition.

Key Facts

  • Acquisition price of $16.25 per share in a stock transaction (Tempus may elect cash up to 50% of consideration)
  • Total enterprise value of $1.5 billion, net of Tempus' existing ownership interest
  • 6% premium to Friday's closing price and 28% premium to unaffected 30-day VWAP
  • Preliminary Q2 2026 revenue of $22.4 million and 10,384 clinical tests (33% sequential growth)
  • Closing expected in late 2026 or early 2027, subject to Personalis shareholder approval and regulatory clearances
  • Tempus has the option to pay cash, capped at 50% of consideration, financed with cash on hand and credit facilities

Financial Impact

Enterprise value of $1.5B; $16.25 per share consideration; preliminary Q2 revenue $22.4M

revenueclinical test volumemarket capitalization

Risk Factors

  • Shareholder approval may not be obtained
  • Regulatory approvals could be delayed or denied
  • Tempus stock price falling below $46 per share gives Personalis the right to terminate the merger agreement
  • Integration risks and potential disruption to business operations during the pendency

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-308488
Document: d68794dex991.htm0001193125-26-308488
Document: 0001193125-26-308488-index-headers.html0001193125-26-308488
Document: 0001193125-26-308488-index.html0001193125-26-308488
Document: 0001193125-26-308488.txt0001193125-26-308488
8-K Data (Synthetic)0001193125-26-308488
14 reports for PSNL
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +14.48%Aug 9, 2026
Filters
Rows
Reports for PSNL — sortable, filterable
TypeNow
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$14.50 $16.60▲ +14.48%▲ +15.40%$16.28 (+12.28%)
Jul 20, 2026
10w ago
425
BULLISH ★ 7/10
$13.44 $13.91▲ +3.50%▲ +0.94%$16.28 (+21.13%)
Jul 20, 2026
10w ago
8-K
NEUTRAL ★ 6/10
$13.44 $13.91▲ +3.50%▲ +0.94%$16.28 (+21.13%)
Jul 20, 2026
10w ago
425
BULLISH ★ 7/10
$13.34 $13.89▲ +4.12%▲ +0.00%$16.28 (+22.04%)
Jul 20, 2026
10w ago
8-K
BULLISH ★ 7/10
$13.34 $13.89▲ +4.12%▲ +0.00%$16.28 (+22.04%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 4/10
$15.58 $14.42▼ −7.45%▼ −11.06%$16.28 (+4.49%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$13.40 $11.98▼ −10.60%▼ −9.57%$16.28 (+21.49%)
Jun 26, 2026
14w ago
144
NEUTRAL ★ 3/10
$13.75 $11.78▼ −14.33%▼ −14.05%$16.28 (+18.40%)
Jun 26, 2026
14w ago
144
NEUTRAL ★ 2/10
$13.75 $11.78▼ −14.33%▼ −14.05%$16.28 (+18.40%)
Jun 6, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$10.04 $14.34▲ +42.83%▲ +41.20%$16.28 (+62.15%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (64h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access